looksthread
Pharmaceutical
PharmaceuticalSkin Prescription

Isotretinoin

Also known as Accutane, oral retinoid

The only drug that reliably produces long-term remission of severe acne. Serious enough that it demands a dermatologist, monitoring and genuine informed consent.

Evidence
Very strong
Typical cost
$200 – $3k
Permanence
Permanent
Timeline
Often an initial flare in weeks 2–6, marked clearing by months 3–5, with a full course of 5–8 months.

Highly dependent on insurance and country. Generic courses can be a few hundred dollars; uninsured US courses with monitoring run far higher.

How it works

An oral retinoid that shrinks sebaceous glands, drastically reduces sebum output, normalises follicular keratinisation and reduces C. acnes colonisation. The gland atrophy is what makes remission durable.

How it's used

Prescribed and monitored by a dermatologist, typically dosed by body weight toward a cumulative target dose over 5–8 months. Requires baseline and periodic blood work (lipids, liver enzymes) and, for anyone who can become pregnant, strict pregnancy prevention with regular testing.

Trade-offs

In favour

  • Can produce permanent remission where every other treatment fails
  • Resolves cystic and scarring acne that would otherwise leave permanent marks
  • Well-defined, finite course rather than indefinite maintenance

Against

  • Substantial side-effect burden
  • Requires ongoing medical supervision and blood monitoring
  • Severely drying — lips, eyes, skin and nasal mucosa
  • Relapse possible, and some need a second course

Risks and side effects

Read before deciding
  • Extremely teratogenic — mandatory pregnancy prevention programmes exist for this reason
  • Raised triglycerides and liver enzymes
  • Dryness, epistaxis, myalgia, night vision changes
  • Mood changes have been reported; discuss personal and family psychiatric history with your prescriber

How good is the evidence?

Very strong
Extensive high-quality evidence and guideline support.

Decades of trial and registry data. Efficacy for severe nodulocystic acne is not seriously disputed; the debate is over dosing strategy and monitoring.

Sources

Sources point to guideline bodies and literature searches rather than single papers, so they stay accurate as the evidence moves.

Discuss this in the forum

Open threads

More in Pharmaceutical